Clinical Trials Logo

Basal Cell Carcinoma clinical trials

View clinical trials related to Basal Cell Carcinoma.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04510727 Withdrawn - Clinical trials for Basal Cell Carcinoma

Optical Coherence Tomography Guided C&D

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

The purpose of the study is to identify the presence of residual superficial and nodular basal cell carcinoma (BCC) status-post curettage and desiccation (C&D) by using optical coherence tomography (OCT).

NCT ID: NCT04099446 Withdrawn - Melanoma (Skin) Clinical Trials

A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin Cancer

Start date: October 2019
Phase:
Study type: Observational

This study seeks to correlate microbial sequencing data from a punch biopsy in patients with skin cancer both melanoma and non-melanoma.

NCT ID: NCT04093401 Withdrawn - Clinical trials for Basal Cell Carcinoma

The VIDYA Study-designed to Determine if Patients With a History of Basal Cell Carcinoma Are More Inclined to Return for Follow-up if Their Risk of a Subsequent Basal Cell Carcinoma is Quantitated.

Start date: June 2021
Phase: N/A
Study type: Interventional

While current guidelines call for annual follow-up for patients with a history of basal cell carcinoma, compliance with these guidelines is imperfect. It is hypothesized that if patients are informed of the quantitative risk of a subsequent basal cell carcinoma based on individualized risk factors, the compliance rate for follow-up will improve. The primary objective of this study is to assess one-year compliance with requested follow-up for patients with recent history of basal cell carcinoma, among those who receive standard sun avoidance counseling and request for follow-up compared to those who receive, in addition, an estimate of their mathematical risk of a subsequent basal cell carcinoma based on individualized risk factors.

NCT ID: NCT03070691 Withdrawn - Clinical trials for Basal Cell Carcinoma

Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

Start date: n/a
Phase: Phase 2/Phase 3
Study type: Interventional

This 22 week study will assess the efficacy, safety, and tolerability of LDE225 versus vehicle when applied topically to basal cell carcinoma (BCC) in patients with NBCCS. Patients will treat multiple BCCs for up to 12 weeks. Treatment success is defined as complete clinical clearance and complete histological clearance in BCCs.

NCT ID: NCT02321982 Withdrawn - Clinical trials for Basal Cell Carcinoma

Same-day Versus Separate-day Preoperative Consultation for Mohs Surgery

Start date: February 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether separate- versus same-day preoperative consultation affects time to treatment (start to finish), utilization rate of Mohs, rate of case cancellations, cost, and patient satisfaction. The investigators hypothesize that patients with same-day preoperative consultation will have a shorter time between cancer diagnosis and removal but, only when coordination of care is needed, longer time between removal and consultation with other specialists, as compared to patients with separate-day consultation. The investigators anticipate that patients with same-day preoperative consultation will have a decrease in travel cost as compared to patients with separate-day consultation. The investigators expect that there will be no difference in various satisfaction matters between groups, with the exception of potentially greater convenience reported by patients in the same-day preoperative consultation group. Finally, the investigators hypothesize that there will be no difference between groups in regards to rates of surgery cancellation.